Low Complication Profile For Pelvic Floor Repair - New Restorelle™ Series Demonstrates Near Zero Mesh Erosion Rate Mpathy Medical, a rapidly growing medical device company which specializes in restoring pelvic
health to women, today announced the findings of a retrospective cohort study carried out by Red Alinsod, MD, FACOG, FACS, ACGE, Laguna Beach, CA.
Source: www.medicalnewstoday.comExercise And Sleep Reduce Women's Cancer Risk A new US study of nearly 6,000 women found that while regular exercise appeared to reduced their risk of cancer, this benefit was likely to be lost if they did not get enough sleep. The researchers presented their findings at the American Association for Cancer Research's (AACR) Seventh Annual International Conference on Frontiers in Cancer Prevention Research that is taking place in National Harbor, Maryland, this week.
Source: www.medicalnewstoday.comAspenBio Pharma Reports On FDA 510(k) Clinical Trial Progress For AppyScore, World's First Blood-Based Diagnostic Test For Human Appendicitis AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel
drugs and diagnostics for humans and animals, reported the enrollment level in the ongoing FDA 510(k) clinical trial for AppyScore™, the world's first blood-based diagnostic test for human appendicitis exceeds 700 patients.
Source: www.medicalnewstoday.comIt's Not Too Late; Get Your Flu Shot Now The Alabama Department of Public
Health encourages the public to get their flu shots. Contact your local
health care provider or county
health department to ask about influenza vaccination. "An ample supply of influenza vaccine remains available this season," said Dr. Donald Williamson, state
health officer.
Source: www.medicalnewstoday.comMuscular Dystrophy Campaign Welcomes Landmark Embryology Act Commenting on the new Human Fertilisation and Embryology Act, Director of Policy and Campaigns, Robert Meadowcroft, said: "The Muscular Dystrophy Campaign wholeheartedly welcomes the passing into law of the Human Fertilisation and Embryology Act.
Source: www.medicalnewstoday.comThe Visible Body, The First Comprehensive 3D Human Anatomy Visualization And Learning Tool, Now Cross-Platform And Cross-Browser Argosy Publishing, an award-winning interactive visual content developer, announced that the Visible Body™ (http://www.visiblebody.com) -- the first free, Web-based 3D interactive model of the human body -- is available now for the first time on Mac®. The Visible Body can now also be accessed using Firefox® and Safari®, in addition to Internet Explorer®.
Source: www.medicalnewstoday.comExperimental Drug RGN-259 Promotes Healing In Patients With Non-Healing Corneal Ulcers - Four Patients Treated Under "Compassionate Use" IND REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) announced today that its ophthalmic drug candidate, RGN-259, was used to treat four neurotrophic keratitis patients with non-healing eye ulcers caused primarily by the herpes zoster virus under a "Compassionate Use" IND (Investigational New Drug application).
Source: www.medicalnewstoday.comSunshine Deficit May Diminish Vitamin D Levels And Harm Cardiovascular Health The temperature might not be the only thing plummeting this winter. Many people also will experience a decrease in their vitamin D levels, which can play a role in heart disease, according to a new review article in Circulation. Vitamin D deficiency results in part from reduced exposure to sunlight, which is common during cold weather months when days are shorter and more time is spent indoors.
Source: www.medicalnewstoday.comLearning Complicated Tasks Requires Sleep Sleep helps the mind learn complicated tasks and helps people recover learning they otherwise thought they had forgotten over the course of a day, research at the University of Chicago shows.
Source: www.medicalnewstoday.com'Enlightened' Atoms Stage Nano-Riot Against Uniformity When atoms in a crystal are struck by laser light, their electrons, excited by the light, typically begin moving back and forth together in a regular pattern, resembling nanoscale soldiers marching in a lockstep formation. But according to a new theory developed by Johns Hopkins researchers, under the right conditions these atoms will rebel against uniformity.
Source: www.medicalnewstoday.com
Cyclosporin Human Neuroprotection Validated By Maas Biolab Scientists Maas Biolab researchers CSO Eskil Elmér, M.D., Ph.D. and neuroscientist Magnus Hansson, M.D., Ph.D., and colleagues have for the first time ever demonstrated the mitochondrial permeability transition (mPT) or "megapore" occurs in viable adult human neuron mitochondria and the ability of cyclosporin-A to block its formation. These effects had previously been well characterized in animal neuroprotection studies and have now been validated in human brain tissue.
Source: www.medicalnewstoday.com
1 In 4 Gulf War Veterans Suffer From Illness Caused By Toxic Exposure At least one in four of the 697,000 U.S. veterans of the 1991 Gulf War suffer from Gulf War illness, a condition caused by exposure to toxic chemicals, including pesticides and a drug administered to protect troops against nerve gas, and no effective treatments have yet been found, a federal panel of scientific experts and veterans concludes in a landmark report released Monday.
Source: www.medicalnewstoday.com8,000 Pharmaceutical Scientists To Gather In Atlanta For The American Association Of Pharmaceutical Scientists' Annual Meeting And Exposition On November 16-20, 2008, 8,000 of the world's most prominent pharmaceutical scientists will put their best research on paper and present their findings at the AAPS Annual Meeting and Exposition. This year's meeting will take place in Atlanta at the Georgia World Congress Center.
Source: www.medicalnewstoday.comCooling The Brain Prevents Cell Death In Young Mice Exposed To Anesthesia New research from Washington University School of
Medicine in St. Louis suggests cooling the brain may prevent the death of nerve cells that has been observed in infant mice exposed to anesthesia. The effects of anesthesia on human infants and young children have been debated among neuroscientists, but growing evidence suggests exposure to anesthetic
drugs during brain development may contribute to behavioral and developmental delays.
Source: www.medicalnewstoday.comFREEDOM-C Trial Of Oral Treprostinil In Pulmonary Arterial Hypertension Fails To Meet Primary Endpoint United Therapeutics Corporation (Nasdaq: UTHR) announced the results of the FREEDOM-C trial of oral treprostinil, a sustained-release formulation of treprostinil, in pulmonary arterial hypertension (PAH). Preliminary analysis demonstrates that the trial did not achieve statistical significance for the primary endpoint, six minute walk (6MW) distance at Week 16.
Source: www.medicalnewstoday.comChronic Plaque Psoriasis - 2nd Case Of Progressive Multifocal Leukoencephalopathy In A Raptiva Patient Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear
Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopathy (PML) which resulted in the death of a 73-year old woman who had received Raptiva® (efalizumab) for approximately four years for treatment of chronic plaque psoriasis.
Source: www.medicalnewstoday.comGeneThera Releases Results From Initial Animal Tests Of E.Coli O157:h7 Vaccine Amid News Of Increase Of E.Coli Discoveries In Beef Products GeneThera, Inc. (Pink Sheets: GTHR), released information about its E.Coli O157:H7 vaccine. The vaccine consists of Live Attenuated Bacterial Vaccine to Reduce or Inhibit Carriage and Shedding of Enterohemorrihagic Escherichia Coli in Cattle. This vaccine was developed for use against Shiga toxin-producing E.Coli (STEC) in cattle. This strategy is to construct mutants that have deletion in the genes responsible for E.Coli O157:H7 toxicity.
Source: www.medicalnewstoday.comFDA Clears The DPL (Deep Penetrating Light) Therapy System For Over-the-Counter - Home Use LED Technologies, LLC announced today that the U.S. Food and Drug Administration (FDA) cleared their DPL™ Therapy System for the relaxation of muscles and relief of muscle spasms, temporary relief of minor muscle and joint aches, pains and stiffness; temporary relief of minor pain and stiffness associated with arthritis; and to temporarily increase local blood circulation.
Source: www.medicalnewstoday.comGrape Powder Alleviates Joint Inflammation - Constituents In Grapes Have Antihyperalgesic Effects In A Rat Model Of Joint Inflammation Johns Hopkins Researchers at Neuroscience 2008 - Table grapes are high in flavonoids, which are thought to have strong antioxidant and anti-inflammatory properties. Now, researchers at the Johns Hopkins University School of
Medicine have shown that powdered grapes appear to reduce pain and inflammation in a rat model of arthritis, where rats knees are inflamed using a chemical injection.
Source: www.medicalnewstoday.comEGFR-Targeting Antibody Licensed To Abbott The international Ludwig Institute for Cancer Research (LICR) has announced that one of its spin-off companies, Life Science Pharmaceuticals, has licensed its lead cancer therapy candidate, antibody 806, to pharmaceutical company Abbott. The 806 antibody targets the EGFR cell surface protein but - crucially - only when the protein is over-expressed (over-produced) in cancer. Overexpression of EGFR occurs in more than 50% of some types of cancers.
Source: www.medicalnewstoday.comPrometheus Presents New Clinical Insights Into Diagnosis Of Crohn's Disease In Children From Analysis Of PROMETHEUS(R) IBD Serology 7 Test Results Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced new findings regarding the correlation between serologic markers and the diagnostic predictions of children with Crohn's disease following an analysis of PROMETHEUS(R) IBD Serology 7 test results.
Source: www.medicalnewstoday.com
